{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:36:28Z","timestamp":1791563788479,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["F 5\/4\/150\/5"],"award-info":[{"award-number":["F 5\/4\/150\/5"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["FC 54372"],"award-info":[{"award-number":["FC 54372"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["5\/4\/150\/5"],"award-info":[{"award-number":["5\/4\/150\/5"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jaip.2021.01.030","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T12:21:14Z","timestamp":1612527674000},"page":"2426-2439.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["CD3\u2212CD4+ Lymphocytic Variant Hypereosinophilic Syndrome: Diagnostic Tools Revisited"],"prefix":"10.1016","volume":"9","author":[{"given":"Caroline","family":"Carpentier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliane","family":"Schanden\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Dewispelaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Cogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Roufosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.01.030_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.01.030_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197501000-00001","article-title":"The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature","volume":"54","author":"Chusid","year":"1975","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2021.01.030_bib3","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A\u00a0tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.01.030_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.iac.2007.07.002","article-title":"Lymphocytic variant hypereosinophilic syndromes","volume":"27","author":"Roufosse","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2021.01.030_bib5","first-page":"1086","article-title":"CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder","volume":"100","author":"Lefevre","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jaip.2021.01.030_bib6","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jaci.2006.02.042","article-title":"Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report","volume":"117","author":"Klion","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.01.030_bib7","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/blood-2014-11-551614","article-title":"How I treat hypereosinophilic syndromes","volume":"126","author":"Klion","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2021.01.030_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev.med.54.101601.152431","article-title":"The hypereosinophilic syndrome revisited","volume":"54","author":"Roufosse","year":"2003","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaip.2021.01.030_bib9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jaip.2017.06.006","article-title":"Hypereosinophilic syndrome subtype predicts responsiveness to glucocorticoids","volume":"6","author":"Khoury","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.01.030_bib10","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3389\/fimmu.2020.01765","article-title":"Eosinophilia associated with CD3-CD4+ T cells: characterization and outcome of a single-center cohort of 26 patients","volume":"11","author":"Carpentier","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2021.01.030_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MD.0000000000000088","article-title":"The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype","volume":"93","author":"Lefevre","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2021.01.030_bib12","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/ajh.25617","article-title":"World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management","volume":"94","author":"Shomali","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaip.2021.01.030_bib13","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM199910073411503","article-title":"Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia","volume":"341","author":"Simon","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.01.030_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1027318530127","article-title":"CD4+ CD7- T cells: a separate subpopulation of memory T cells?","volume":"17","author":"Reinhold","year":"1997","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2021.01.030_bib15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.autrev.2018.02.001","article-title":"TCRalphabeta(+)CD3(+)CD4(-)CD8(-) (double negative) T cells in autoimmunity","volume":"17","author":"Brandt","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaip.2021.01.030_bib16","author":"Hu"},{"key":"10.1016\/j.jaip.2021.01.030_bib17","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM198406213102501","article-title":"Episodic angioedema associated with eosinophilia","volume":"310","author":"Gleich","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.01.030_bib18","author":"Abisror"},{"key":"10.1016\/j.jaip.2021.01.030_bib19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3324\/haematol.2013.091264","article-title":"Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder","volume":"100","author":"Khoury","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jaip.2021.01.030_bib20","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3324\/haematol.2009.010421","article-title":"Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations","volume":"94","author":"Roufosse","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.jaip.2021.01.030_bib21","first-page":"17","article-title":"Cell clonality in hypereosinophilic syndrome: what pathogenetic role?","volume":"25","author":"Galimberti","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaip.2021.01.030_bib22","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3324\/haematol.2008.005447","article-title":"T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome","volume":"94","author":"Helbig","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.jaip.2021.01.030_bib23","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.exphem.2005.06.027","article-title":"Defective CD3gamma gene transcription is associated with NFATc2 overexpression in the lymphocytic variant of hypereosinophilic syndrome","volume":"33","author":"Willard-Gallo","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jaip.2021.01.030_bib24","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1182\/blood.V94.3.994.415k26_994_1002","article-title":"T-cell receptor-independent activation of clonal Th2 cells associated with chronic hypereosinophilia","volume":"94","author":"Roufosse","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2021.01.030_bib25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/eji.201646373","article-title":"FOXP1 is a regulator of quiescence in healthy human CD4(+) T cells and is constitutively repressed in T cells from patients with lymphoproliferative disorders","volume":"47","author":"Garaud","year":"2017","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2021.01.030_bib26","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaip.2019.08.049","article-title":"Assessment of T-cell polarization on the basis of surface marker expression: diagnosis and potential therapeutic implications in lymphocytic variant hypereosinophilic syndrome","volume":"8","author":"Ledoult","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.01.030_bib27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/1521-4141(200104)31:4<1037::AID-IMMU1037>3.0.CO;2-#","article-title":"Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in\u00a0vivo","volume":"31","author":"de Lavareille","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2021.01.030_bib28","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1067\/mai.2002.127003","article-title":"High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome","volume":"110","author":"de Lavareille","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.01.030_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2003.132","article-title":"Thymus and activation-regulated chemokine (TARC\/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides","volume":"48","author":"Kakinuma","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2021.01.030_bib30","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/bjd.16132","article-title":"Serum thymus and activation-regulated chemokine is associated with the severity of drug reaction with eosinophilia and systemic symptoms\/drug-induced hypersensitivity syndrome","volume":"178","author":"Nakamura-Nishimura","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2021.01.030_bib31","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1111\/jdv.16851","article-title":"Serum thymus and activation-regulated chemokine (TARC\/CCL17) may be useful to predict the disease activity in patients with bullous pemphigoid","volume":"35","author":"Suzuki","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2021.01.030_bib32","doi-asserted-by":"crossref","first-page":"6.24.1","DOI":"10.1002\/0471142735.im0624s110","article-title":"Detection of intracellular cytokines by flow cytometry","volume":"110","author":"Yin","year":"2015","journal-title":"Curr Protoc Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821001586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821001586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:12:34Z","timestamp":1778523154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821001586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2213219821001586"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.01.030","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD3\u2212CD4+ Lymphocytic Variant Hypereosinophilic Syndrome: Diagnostic Tools Revisited","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}